Advinus' Commitment to Quality 

The Society of Quality Assurance (SQA) Annual Meeting was held in conjunction with the SQA Quality College in Maryland, USA.  The purpose of this conference is to promote quality among the regulated research community. Advinus Therapeutics is committed to providing the best and the most informed regulatory requirements to all its sponsors. In keeping with our values and legacy, Dr. Natesan Settiagounder (Vice President and Head, Corporate Quality Assurance) and Mr. Satish Murthy (Head, GLP section, QAU) participated in the latest SQA conference.
 
Several updates were presented in the context of regulatory requirements for GLP, GMP, GCP and medical devices compliance, in addition to the latest published Advanced Notice of Proposed Rule Making by the FDA for GLP (21 CFR Part 58) and discussions.
 
Some key highlights from the conference: